Beta-adrenergic agonist-mediated desensitization in senescent rats

Area of Science:

• Cardiovascular Physiology
• Aging Research
• Pharmacology

Background:

• Beta-adrenergic receptor responsiveness is crucial for cardiac function.
• Aging can alter receptor sensitivity and signaling pathways.
• Catecholamine refractoriness is a state of reduced response to adrenergic agonists.

Purpose of the Study:

• To investigate the capacity of senescent rats to develop a catecholamine refractory state.
• To compare beta-adrenergic receptor function in young and aged rats following chronic agonist administration.
• To determine if age impairs catecholamine desensitization of myocardial beta-adrenergic responsiveness.

Main Methods:

• Chronic in vivo administration of the beta-adrenergic agonist metaproterenol to CDF (F-344) rats (3 and 24 months old).
• Assessment of myocardial beta-adrenergic receptor number, receptor-agonist affinity, and adenylate cyclase activity in heart membranes.
• Evaluation of catecholamine-refractoriness and agonist desensitization effects.

Main Results:

• Metaproterenol treatment induced myocardial hypertrophy, receptor down-regulation, and reduced adenylate cyclase activity in both age groups.
• The extent of catecholamine-refractoriness was comparable between 3-month-old and 24-month-old rats.
• Receptor agonist affinity and high-affinity state decreased with age and were further reduced by agonist treatment, but less so in older rats.

Conclusions:

• Catecholamine desensitization of myocardial beta-adrenergic responsiveness is not impaired in senescence.
• Age and agonist desensitization effects are not additive, suggesting aged animals may be partially desensitized.
• Findings indicate that aging does not hinder the development of catecholamine refractoriness.